Author | Year | Tests used | Metastatic rate (%) |
---|---|---|---|
LFTs, liver function tests; CXR, chest x ray; CT, computed tomography; COMS, collaborative ocular melanoma study. | |||
*Further imaging (CT/MRI) done if liver enzyme assays abnormal. | |||
Wagoner19 | 1982 | LFTs, liver spleen scan | 2.47 |
Pach20 | 1986 | LFTs, CXR, liver scan or CT abdomen | 2.2 |
COMS6 | 2004 | LFTs, CXR* | <1 |
This study | 2005 | PET/CT | 3.8 |